[HTML][HTML] Treatment strategies for hepatocellular carcinoma—a multidisciplinary approach

I Lurje, Z Czigany, J Bednarsch, C Roderburg… - International journal of …, 2019 - mdpi.com
Hepatocellular carcinoma (HCC) is the most common primary tumor of the liver and its
mortality is third among all solid tumors, behind carcinomas of the lung and the colon …

Immunomodulation and targeted drug delivery with high intensity focused ultrasound (HIFU): Principles and mechanisms

H Ashar, A Ranjan - Pharmacology & Therapeutics, 2023 - Elsevier
High intensity focused ultrasound (HIFU) is a non-invasive and non-ionizing sonic energy-
based therapeutic technology for inducing thermal and non-thermal effects in tissues …

[HTML][HTML] Irreversible electroporation and electrochemotherapy in oncology: State of the art

JP Tasu, D Tougeron, MP Rols - Diagnostic and Interventional Imaging, 2022 - Elsevier
Thermal tumor ablation techniques including radiofrequency, microwave, LASER, high-
intensity focused ultrasound and cryoablation are routinely used to treated liver, kidney …

[HTML][HTML] Irreversible electroporation: an emerging immunomodulatory therapy on solid tumors

N Zhang, Z Li, X Han, Z Zhu, Z Li, Y Zhao… - Frontiers in …, 2022 - frontiersin.org
Irreversible electroporation (IRE), a novel non-thermal ablation technique, is utilized to
ablate unresectable solid tumors and demonstrates favorable safety and efficacy in the …

[HTML][HTML] Immunological effects of histotripsy for cancer therapy

A Hendricks-Wenger, R Hutchison… - Frontiers in …, 2021 - frontiersin.org
Cancer is the second leading cause of death worldwide despite major advancements in
diagnosis and therapy over the past century. One of the most debilitating aspects of cancer …

Irreversible electroporation induces CD8+ T cell immune response against post-ablation hepatocellular carcinoma growth

Z Dai, Z Wang, K Lei, J Liao, Z Peng, M Lin, P Liang… - Cancer Letters, 2021 - Elsevier
Ablative treatment evokes antitumor immunity, but knowledge on the emerging irreversible
electroporation (IRE)-induced immunity in hepatocellular carcinoma (HCC) is limited. To …

[HTML][HTML] Multidisciplinary management of liver metastases in patients with colorectal cancer: a consensus of SEOM, AEC, SEOR, SERVEI, and SEMNIM

R Vera, E González-Flores, C Rubio, J Urbano… - Clinical and …, 2020 - Springer
Colorectal cancer (CRC) has the second-highest tumor incidence and is a leading cause of
death by cancer. Nearly 20% of patients with CRC will have metastases at the time of …

[HTML][HTML] Image-guided ablation for colorectal liver metastasis: principles, current evidence, and the path forward

YM Lin, I Paolucci, KK Brock, BC Odisio - Cancers, 2021 - mdpi.com
Simple Summary Colorectal cancer is the fourth most common type of cancer globally.
Approximately 20% of patients with colorectal cancer present with synchronous liver …

The latest research progress on minimally invasive treatments for hepatocellular carcinoma

YW Zou, ZG Ren, Y Sun, ZG Liu, XB Hu… - … & Pancreatic Diseases …, 2023 - Elsevier
Background Hepatocellular carcinoma (HCC) is the fourth leading cause of cancer-related
death worldwide. Due to the high prevalence of hepatitis B virus (HBV) infection in China …

Efficacy and safety of irreversible electroporation for malignant liver tumors: a systematic review and meta-analysis

P Gupta, M Maralakunte, S Sagar, P Kumar-M… - European …, 2021 - Springer
Objective The data regarding overall survival (OS) and progression-free survival (PFS)
following irreversible electroporation (IRE) is scarce. We performed a systematic review of …